Viewing Study NCT02982694

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2026-05-15 @ 5:38 AM
Study NCT ID: NCT02982694
Status: TERMINATED
Last Update Posted: 2025-10-01
First Post: 2016-12-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal Cancer
Sponsor: Vall d'Hebron Institute of Oncology
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None MSI View
None ColoRectal Cancer View
None Chemotherapy View
None Resistance, APC View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MSI View
None colorectal View
None chemotherapy View
None Bevacizumab View
None Atezolizumab View